A critical review of the effects of vitamin K on glucose and lipid homeostasis: its potential role in the prevention and management of type 2 diabetes

HORMONES ◽  
2021 ◽  
Author(s):  
Nikolaos A. Varsamis ◽  
Georgios A. Christou ◽  
Dimitrios N. Kiortsis
2020 ◽  
Vol 18 ◽  
pp. 811-823 ◽  
Author(s):  
Huiying Gu ◽  
Wei Jiang ◽  
Nan You ◽  
Xiaobing Huang ◽  
Yuming Li ◽  
...  

Author(s):  
Mathias Z. Strowski

AbstractFibroblast growth factor 21 (FGF21) plays a role in regulating adaptation to various metabolic abnormalities. In addition, FGF21 is involved in controlling glucose and lipid homeostasis. The regulation of FGF21 is a complex process and depends upon multiple metabolic factors and hormones. Humans and animals with obesity or type 2 diabetes have abnormal expression and changes of FGF21 in the circulation. Interventional studies in rodents and monkeys with obesity, insulin resistance or type 2 diabetes revealed a potential therapeutic relevance of FGF21 in correcting these abnormalities. This review summarizes the current knowledge about the regulation of FGF21 by distinct metabolic and endogenous factors, considering the most relevant studies. In this context, the results of interventional studies in humans and various animal models of diseases, such as diabetes and obesity, are discussed. In addition, potential mechanisms of the molecular regulation of FGF21 expression and secretion are reviewed.


Gut Pathogens ◽  
2021 ◽  
Vol 13 (1) ◽  
Author(s):  
A. L. Cunningham ◽  
J. W. Stephens ◽  
D. A. Harris

AbstractA strong and expanding evidence base supports the influence of gut microbiota in human metabolism. Altered glucose homeostasis is associated with altered gut microbiota, and is clearly associated with the development of type 2 diabetes mellitus (T2DM) and associated complications. Understanding the causal association between gut microbiota and metabolic risk has the potential role of identifying susceptible individuals to allow early targeted intervention.


2015 ◽  
Vol 19 (4) ◽  
pp. 230-237 ◽  
Author(s):  
Manshu Song ◽  
Feifei Zhao ◽  
Longjin Ran ◽  
Mamatyusupu Dolikun ◽  
Lijuan Wu ◽  
...  

2016 ◽  
Vol 21 (12) ◽  
pp. 1726-1732 ◽  
Author(s):  
N Schmitz ◽  
S S Deschênes ◽  
R J Burns ◽  
K J Smith ◽  
A Lesage ◽  
...  

Biomolecules ◽  
2020 ◽  
Vol 10 (4) ◽  
pp. 601
Author(s):  
Aditya Saxena ◽  
Nitin Wahi ◽  
Anshul Kumar ◽  
Sandeep Kumar Mathur

The pathogenic mechanisms causing type 2 diabetes (T2D) are still poorly understood; a greater awareness of its causation can lead to the development of newer and better antidiabetic drugs. In this study, we used a network-based approach to assess the cellular processes associated with protein–protein interaction subnetworks of glycemic traits—HOMA-β and HOMA-IR. Their subnetworks were further analyzed in terms of their overlap with the differentially expressed genes (DEGs) in pancreatic, muscle, and adipose tissue in diabetics. We found several DEGs in these tissues showing an overlap with the HOMA-β subnetwork, suggesting a role of these tissues in β-cell failure. Many genes in the HOMA-IR subnetwork too showed an overlap with the HOMA-β subnetwork. For understanding the functional theme of these subnetworks, a pathway-to-pathway complementary network analysis was done, which identified various adipose biology-related pathways, containing genes involved in both insulin secretion and action. In conclusion, network analysis of genes showing an association between T2D and its intermediate phenotypic traits suggests their potential role in beta cell failure. These genes enriched the adipo-centric pathways and were expressed in both pancreatic and adipose tissue and, therefore, might be one of the potential targets for future antidiabetic treatment.


Sign in / Sign up

Export Citation Format

Share Document